Cancer Biology & Medicine2026，Vol.23Issue(1)：P.133-153,21.DOI:10.20892/j.issn.2095-3941.2025.0326
Antitumor effects of STING agonists on nervous system tumors via tumor-intrinsic STING-STAT1-mediated HMGN2 expression
Zijian Lv 1Tiance Wang 1Runjia Fan 1Qianyi Ming 1Jiejie Liu 1Yulin Jia 1Yan Zhang 1Meixia Chen 1Wei Chen 2Zhengfan Jiang 3Weidong Han 4Qian Mei1
作者信息
- 1. Department of Bio-Therapeutic,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,China
- 2. Department of Pathology,The Fifth Medical Center,Chinese PLA General Hospital,Beijing 100853,China
- 3. Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education,School of Life Sciences,Peking University,Beijing 100871,China
- 4. Department of Bio-Therapeutic,The First Medical Center,Chinese PLA General Hospital,Beijing 100853,China Changping Laboratory,Beijing 102206,China
- 折叠
摘要
关键词
STING agonists/SR-717/tumor immunity/HMGN2/biomarker分类
医药卫生引用本文复制引用
Zijian Lv,Tiance Wang,Runjia Fan,Qianyi Ming,Jiejie Liu,Yulin Jia,Yan Zhang,Meixia Chen,Wei Chen,Zhengfan Jiang,Weidong Han,Qian Mei..Antitumor effects of STING agonists on nervous system tumors via tumor-intrinsic STING-STAT1-mediated HMGN2 expression[J].Cancer Biology & Medicine,2026,23(1):P.133-153,21.
